Doxazosin Tablet
Product Images NDC 70518-4031

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 70518-4031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Doxazosin 4 mg oral tablets packaging label from RemedyRepack Inc. It indicates a quantity of 90 tablets. The label includes a barcode, NDC number 70518-4031-00, and storage instructions. Manufacturing is attributed to Apotex Corp., Weston, FL.*

FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

Chemical structure of doxazosin, showing its molecular components including multiple rings, methoxy groups, an amino group, and a methanesulfonate (CH3SO3H) component.*

FDA Label Image

Figure1.jpg (Figure1)

A dual line graph comparing Doxazosin and placebo effects over 14 weeks. The left graph shows mean change in total symptom score from baseline, with Doxazosin demonstrating a greater reduction than placebo. The right graph depicts mean increase in maximum urinary flow rate from baseline, with Doxazosin showing a larger increase. Both graphs include sample sizes and significance markers.*

FDA Label Image

Table3.jpg (Table3)

A table summarizing effectiveness data from three placebo-controlled clinical trials of doxazosin. It presents symptom scores and maximum flow rate values at baseline and mean change, comparing placebo and various doxazosin doses, along with a bar graph for study 2 illustrating changes in symptom score and maximum flow rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.